In addition, K-Ras, B-Raf and PIK3CA mutation burden ranged from 11 to 99%, 12 to 65% and 14 to 54% of cells, respectively, highlighting marked inter-tumour heterogeneity in mutation burden (Figure 1). Here, BRAF is linked to neoplasm.